NOV 12, 2015 2:47 PM PST

Regulating the Immune Response to Relieve IBD Symptoms

WRITTEN BY: Kara Marker
Scientists from the Beth Israel Deaconess Medical Center (BIDMC) have been studying immune action in cases of inflammatory bowel disease (IBD) for more than ten years. This week, they discovered a connection between immune cells and cytokine signaling that could change the way people live with IBD. 

According to the CDC, common types of IBD like Crohn's disease and ulcerative colitis affect more than a million Americans. These diseases are characterized by chronic inflammation of the gastrointestinal (GI) tract due to an unwarranted immune response. The immune cells act as if normal compounds in the GI tract are foreign and dangerous. 

The basic premise of IBD involves the unregulated action of effector immune cells in the GI tract; cytokines are released and stimulate inflammation of the bowels even though no pathogens or damages are present. The scientists from the BIDMC study the two immune cells involved in the troubling IBD immune response: CD4 T cells and Type 1 CD8+ T cells (TC1).

Specifically in Crohn's disease, TC1 cells produce interferon gamma, a cytokine that induces inflammation. Normally, regulatory immune cells inhibit the action of TC1 cells when no action is required, but Crohn's disease patients are chronically unable to perform this maintainence. To make up for this malfunction, the scientists looked at the expression of CD39, an ectoenzyme, on TC1 to see if they could halt the overproduction of interferon gamma.

Ectoenzymes like CD39 have their enzymatically active site outside the plasma membrane, in the extracellular environment. CD39 is naturally expressed by dendritic cells and some regulatory cells and acts as an immunosuppressive.

CD39 is able to regulate the autoimmune reactions in Crohn's disease through "catalytic conversion of proinflammatory extracelluar ATP to immunosuppressive nucleosides" like adenoside, a behavior used by the BIDMC scientists over the past decade as they looked for a way to counter the effect of IBD. Essentially, this enzyme transforms the energy produced by the GI tract inflammation into a product that suppresses the inflammation. 

To conclude their study, the scientists from BIDMC were able to put all of the pieces together by discovering that upregulation of CD39 in IBD patients helped suppress and inhibit interferon gamma production in neighboring TC1 cells. This connection leads to promising new treatment plans for IBD patients, manipulating the body's natural way of controlling inflammation.

Check out the video below to learn more about Crohn's disease and how inflammation of the GI tract affects digestion. 

Source: Medical Xpress



 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 22, 2019
Immunology
JUL 22, 2019
How to Kill Superbugs
https://www.technologynetworks.com/immunology/news/enhancing-the-infection-fighting-potential-of-natural-products-321553...
SEP 27, 2019
Drug Discovery & Development
SEP 27, 2019
AI Exponentially Accelerates Drug Development
Research and development for new drugs is both an expensive and lengthy process, often lasting years, if not decades. With the development of artificial in...
OCT 25, 2019
Drug Discovery & Development
OCT 25, 2019
Novel Therapeutic For Eradicating The Flu Virus
Public Health officials have long warned about pandemic pathogens flying fast around the world. One virus already spreads across the globe annually leading...
NOV 29, 2019
Immunology
NOV 29, 2019
Protecting Killer Immune Cells from Themselves
Destroying human cells compromised by viruses and cancer is the name of the game for so-called “killer” cells of the immune system. They employ...
DEC 04, 2019
Immunology
DEC 04, 2019
Predicting Death with Clinical Immune Indicators
Immune and inflammation status could help doctors predict which individuals are most at-risk for death. Results from a new study mark the first step toward...
FEB 07, 2020
Neuroscience
FEB 07, 2020
Eating Fruits and Vegetables May Lower Alzheimer's Risk
New research has found that flavonols, a large class of compounds present in many fruits and vegetables, may be linked to a lower risk of developing Alzhei...
Loading Comments...